From IT Tool to Workforce: How Agentic AI Is Redefining Healthcare Delivery

Healthcare is at an inflection point where artificial intelligence is being reframed not as an IT tool, but as a workforce solution. This shift in mindset is profound: instead of treating AI like another software install (and squeezing it into the typical 2–3% IT budget of a provider), forward-thinking healthcare leaders are treating AI as “digital labor” – a new category of workforce that can take on tasks traditionally performed by people. The implications are huge. Labor makes up roughly 60% of a hospital’s costs, dwarfing typical IT spend. By tapping into that labor budget and solving staffing pain points, AI solutions are unlocking faster adoption and commanding larger budgets than if they were pitched as standard IT products. This insight piece takes a pragmatic, strategic look at why framing AI as a workforce solution is resonating in healthcare. We’ll examine the budget dynamics driving this trend, concrete examples of “agentic AI” in action (from call center assistants to AI care navigators), and the unit economics that make automation-first models so attractive. We’ll also analyze the competitive landscape – from recent mega funding rounds to moves by incumbents like Epic and Microsoft – and provide a founder’s lens on go-to-market (GTM) strategy, ROI framing, regulatory considerations (like steering clear of Software-as-a-Medical-Device classification), and how to build durable moats. We conclude with long-term implications: who stands to capture value as AI labor scales, and how this shift could structurally deflate the cost of care. The goal is to offer healthcare founders (and the investors who back them) an analytical roadmap for navigating the emerging era of AI as a healthcare workforce. Let’s dive in.

The Case for AI as a Workforce Solution

Why position AI as a “workforce solution” in the first place? The answer starts with healthcare’s budget calculus. Hospitals and health systems spend the vast majority of their dollars on people – nurses, physicians, administrative staff, call center reps, care coordinators, you name it. In fact, labor expenses account for about 60% of the average hospital’s budget . In contrast, IT typically represents only a sliver (often ~2–3%) of expenditures . This means that solutions addressing labor costs have a much bigger target to go after. If an AI can credibly reduce staffing needs, augment staff productivity, or cover work that would otherwise require additional hires, it taps into the largest pool of spend in healthcare.

From a buyer’s perspective, this framing changes who gets excited about the technology. Instead of being pigeonholed as another software tool that the CIO needs to justify, an AI workforce solution speaks to COOs, CFOs, and department heads under immense pressure from staffing shortages and wage inflation. These operational leaders control enormous budgets for labor and are actively seeking relief. They’re often willing to pilot and deploy solutions fast if they directly alleviate workforce bottlenecks (for example, reducing overtime, preventing burnout, or enabling smaller teams to handle more volume). In short, positioning AI as digital staff – virtual nurses, AI assistants, automated analysts – opens the door to faster adoption because it addresses an acute pain point. It’s not a “nice-to-have” tech gadget; it’s a strategic workforce lever.

Crucially, treating AI as workforce also tends to justify larger price tags and ROI cases. A hospital might balk at a $500k software license coming out of the IT budget, but if that same $500k AI solution can replace the work of 5 full-time staff (worth, say, $500k in salaries) or dramatically improve throughput, it becomes cost-justified against the labor budget. As one analysis noted, administrative overhead in healthcare is enormous (nearly $1 trillion in the US), yet only ~10% of it is spent on technology today – leaving ample room to redirect manual work to automation. In summary, by aligning AI to the workforce problem, startups are finding far bigger wallet share and receptivity among healthcare organizations than traditional IT pitches ever could.

Budget Reallocation: Tapping a $0.60 Dollar vs a $0.03 Dollar

The budget reallocation opportunity can be illustrated with a simple comparison: $0.60 vs $0.03. For every dollar a provider organization spends, about 60 cents go to labor, and perhaps 2–3 cents to IT . In practical terms, that means a hospital might spend hundreds of millions annually on salaries (nurses, clinicians, billing staff, schedulers, etc.), but maybe only a few million on new software. This disparity has historically limited health IT’s impact – no matter how great a tool is, if it’s lumped into that tiny IT budget, it faces a very constrained economic ceiling.

Agentic AI flips this script. By demonstrating the ability to take on work, not just provide tooling, these solutions are compelling CFOs to reallocate funds from labor budgets into technology. For instance, consider a health system spending $50M a year on call center operations. An AI “digital agent” that could automate a portion of those calls or make each human agent significantly more efficient might justify an investment of several million dollars – far above what the call center would normally get in IT tools – because it’s coming out of that $50M labor line item. We’re effectively seeing tech budgets commandeer part of the labor budget in the name of efficiency. It helps that these investments can often be framed in terms of direct ROI: “This AI will reduce overtime by X%” or “allow us to handle Y more patients without new hires,” etc.

Moreover, the urgency of labor shortages strengthens the case. Coming out of the pandemic, nearly every health organization is grappling with workforce gaps and burnout. The nursing shortage, for example, is projected to be tens of thousands strong for years to come . Administrative staff turnover is high, and hiring qualified people (for roles like medical billing or care coordination) is difficult and costly. In this environment, solutions that reduce reliance on scarce human workers are not just cost savers – they are business continuity and growth enablers. This often means AI projects get accelerated approval because the alternative (not enough staff to handle demand) is not acceptable.

Finally, by focusing on workforce outcomes, AI providers can often sidestep the protracted procurement cycles typical of pure IT systems. Instead of a lengthy RFP competing against established EHR or ERP vendors, an AI workforce solution might be trialed in a specific department as a pilot to fill staffing holes, proving itself in months. Successful pilots then lead to enterprise rollouts funded by productivity gains. The net effect is faster adoption curves than we’ve historically seen for new health IT. In fact, one startup, Hippocratic AI, which offers “healthcare AI agents” for routine patient-facing tasks, signed contracts with 23 health systems and insurers within its first year – a remarkable uptake partly due to positioning itself as a fix for staff shortages (handling simple patient interactions) rather than just another administrative IT tool.

Agentic AI in Action: Examples of the New Digital Workforce

Nothing illustrates this trend better than the startups deploying agentic AI across different healthcare workflows. By agentic AI, we refer to AI systems that act as autonomous or semi-autonomous agents performing tasks with minimal human intervention . These are the digital “workers” – analogous to virtual employees – that can handle specific functions end-to-end. Let’s look at a few concrete examples making waves:

• Cascala Health – AI care transition coordinator: When patients move from hospital to home or between care settings, it’s a precarious time often managed by human care coordinators and case managers. Cascala Health is bringing AI into this care transition management. Billed as a “clinically responsible AI” platform, Cascala’s system monitors discharged patients and orchestrates follow-ups, medication reminders, appointments, and education to prevent readmissions. In essence, it acts as a virtual care navigator that ensures patients don’t fall through the cracks during handoffs . The AI might send reminders, alert a human nurse for intervention if certain risk factors spike, or guide the patient through self-care steps – all tasks that would otherwise require a care manager’s time. By doing so, Cascala helps hospitals and post-acute providers avoid costly readmissions - a $41Bn yearly leakage today(which can incur penalties) and handle larger patient volumes with the same staff. This agentic AI is positioned as a safety net “team member” dedicated 24/7 to care transitions – an area notoriously hard to fully staff because it spans beyond the hospital walls. Providers pay for Cascala much as they would for care management services, but with the expectation that an automated system can scale to many more patients per coordinator, improving margins on value-based contracts and outcomes.
  
  
• Translucent Health – your AI business analyst team: Not all workforce AI targets clinical operations; some aim at the back-office brain work that eats up administrative FTEs. Translucent Health is a great example, branding itself as “AI labor for FP&A” (financial planning & analysis) in provider organizations . Health systems often employ entire analyst teams to crunch data for budgeting, performance improvement, and reporting – an expensive but necessary overhead. Translucent offers a suite of AI “analysts” that automate data aggregation, analysis, and insights generation for hospital finance teams. Think of it as a 24/7 virtual analytics department that can answer questions like “Which service lines are driving our margin variance this quarter?” or “Where can we cut costs without affecting quality?” in seconds, based on integrated data. By automating analysis and reporting tasks and proactively surfacing ROI opportunities , Translucent’s AI agents augment (or potentially replace) some of the costly human analysts. The pitch to hospital CFOs: rather than hiring another analyst at $100k+ or burdening your team with overtime, subscribe to an AI service that delivers analysis on demand. In an era where every health system is trying to do more with less, an AI business analyst team directly converts into labor cost reduction and faster decision-making. It’s easy to see why this resonates – it tackles a “hidden” labor cost (financial admin work) that doesn’t directly improve patient care, thus ripe for automation.
  
  
• DUOS – AI concierge for seniors: DUOS began as a tech-enabled service matching older adults with human “duo” companions to help navigate healthcare and social needs. Now, the company has supercharged its model with an AI platform (DUOS+AI) to scale personalized assistance for seniors. DUOS’s system uses a conversational AI interface and recommendation engine to connect Medicare Advantage members with the right benefits, community resources, and services based on their needs . For example, if a senior is food-insecure and needs transportation to appointments, the AI can identify government meal programs, plan benefits (like a transportation stipend), and even help schedule those services. This is work that care navigators or social workers often do manually over many phone calls. DUOS+AI automates large parts of that discovery and coordination. The result: health plans using DUOS have seen an 86% reduction in the time it takes to find and arrange relevant benefits for a member . That efficiency means each human care manager can support many more members, or plans can reduce outsourced navigation costs. By presenting its solution as an AI-powered extension of the care management team, DUOS appeals to health plans’ desire to improve member satisfaction and outcomes (which drive plan ratings and retention) without linearly scaling headcount. It’s another case of AI acting as force multiplier for an existing workforce – the kind of value prop that unlocks budget in a Medicare Advantage plan eager to address social determinants of health at scale.
  
  

Together, these examples paint a picture of agentic AI being applied up and down the healthcare value chain: from clinical operations to back-office administration and care navigation. In each case, the startups aren’t selling “AI” in the abstract – they’re selling specific labor outcomes ( avoided readmissions, automated analyses, happier seniors) that map to improved margins or quality for the buyer. This concreteness, combined with rapidly improving AI capabilities (thanks to advances in LLMs and voice AI), is what makes this wave of solutions so tangible and attractive. They feel less like science fiction and more like hiring a very permanent, competent, tireless employee – one that comes at a fraction of the cost of a human over time.

Automation-First vs. Tech-Enabled: The Unit Economics

One of the strategic considerations for founders in this space is how much human service to include alongside the AI. Many early healthcare startups took a tech-enabled services approach – combining software with teams of physicians, nurses, or coordinators to deliver a full service (think telehealth companies, or navigation services like the original DUOS model). This often improves outcomes but can suffer from service-like margins and scalability issues. In contrast, the new crop of agentic AI startups are often automation-first, aiming for software-level margins by minimizing human involvement in delivery.

The difference shows up starkly in unit economics. A pure software or automation solution can potentially achieve gross margins in the 70–90% range (after the cost of cloud compute and maintenance) – analogous to SaaS businesses. A tech-enabled service that employs clinicians or operators will have significantly lower gross margins, often in the 30–50% range when small, maybe improving to ~60% at best with scale and efficiency . For example, an analysis by Bessemer Venture Partners compared a $100M run-rate healthcare SaaS business (~70% GM) to a larger $225M run-rate tech-enabled health services business (~45% GM) . The service business had higher revenue but, after adjusting for margins, the enterprise value was actually similar or lower than the smaller pure software business. The takeaway: automation-heavy models can drive much better margin structures, which in turn support higher valuation multiples and more sustainable scaling (since each new customer adds profit, not proportional cost of service delivery).

However, there is a balance to be struck. In healthcare, pure automation can be risky if the AI isn’t ready to handle all edge cases. Many successful models start with a hybrid approach – AI does the heavy lifting, and humans handle exceptions – and gradually increase automation as the AI learns. Founders should think of human involvement as a “training wheel” or fallback that ensures service quality in early stages (and helps navigate any regulatory requirements for human oversight), but with a clear roadmap to removing or reducing that human cost over time. The margin expansion story is a powerful one for investors: it means initial gross margins of maybe 30-50% can improve to 80%+ as the AI takes over more of the work. This stands in contrast to traditional tech-enabled services where humans remain a core cost indefinitely.

There’s also the question of pricing and capturing value. If your AI workforce solution delivers the equivalent of a $100k/year employee’s work, how do you price it? Many startups are experimenting with usage-based or outcome-based pricing (for instance, charging per successful task completed, or a percentage of the value of collections improved, etc.). The good news is that, unlike selling generic software, selling “labor” allows pricing against existing salary or outsourcing benchmarks, which are usually quite high in healthcare. This can justify premium pricing while still offering the buyer a clear cost savings. For example, if a health system typically spends $50 on a manual prior authorization request (in staff time), an AI that does it for $10 still leaves plenty of savings on the table and can pocket a healthy margin. The high cost baseline of healthcare labor creates ample room for win-win value division between customers and AI vendors.

In summary, the agentic AI trend is enabling startups to pursue service-like impact with software-like margins. The most scalable companies will be those that figure out how to maximize automation, ensure quality and safety with minimal human touch, and price based on value delivered rather than traditional software licensing. This combination yields a highly attractive unit economic profile that is drawing significant investor interest – as evidenced by some of the large funding rounds we’ll discuss next.

A Growing Wave: Funding Surge and Incumbent Moves

Investors have taken notice that healthcare AI finally has a clear path to scale (and revenue) by attacking the workforce cost problem. After a somewhat cautious period in digital health funding in 2022–2023, we’re now seeing a surge of capital into what some call the “AI workforce” category. The poster child is Hippocratic AI, which in early 2025 raised a massive $141M Series B at a $1.65B valuation . What’s notable is why Hippocratic attracted such a war chest: it’s building healthcare-specific LLMs to deploy “non-diagnostic, patient-facing” AI agents that alleviate staff workloads . Their agents handle tasks like pre-op instructions, post-discharge check-ins, and appointment prep – exactly those routine tasks that normally consume nurses’ and support staff’s time. By explicitly avoiding diagnostic roles, Hippocratic also sidesteps heavy FDA regulation, focusing on workforce support. With 23 health systems and insurers already signed on in 2024 , their rapid customer uptake demonstrates how hungry the market is for AI labor. The huge Series B reflects a bet that every hospital will want such agents, potentially reducing the strain of workforce shortages and saving millions.

Hippocratic AI is not alone. Other startups in the “agentic AI” arena have also landed big rounds or lofty valuations. In care navigation and coordination, players like NaviHealth (now part of Optum) and Transcarent have begun integrating AI to amplify their human services, and investors continue to fund newcomers attacking similar problems. We also saw funding in 2024 for AI-driven revenue cycle assistants, radiology workflow agents, and mental health coaching bots, among others. A common thread: these companies pitch not just AI accuracy or novelty, but tangible labor substitution or augmentation (e.g. “our AI can handle 80% of prior auth requests” or “we automate patient on-boarding forms completely”). It’s this ROI-centric narrative that’s unlocking big checks even in a somewhat wary venture climate for health tech.

At the same time, incumbent healthcare technology companies are encroaching on this space, keen not to be left behind. Electronic health record giant Epic, for instance, announced a partnership with Microsoft to integrate GPT-4 into its EHR workflow . One of the first use cases is drafting message responses to patients – effectively an AI scribe or assistant for clinicians within the patient portal. Microsoft (via its Azure OpenAI service and the Nuance acquisition) is aggressively positioning itself as the partner-of-choice for implementing generative AI in provider systems . The message is clear: established players see the demand for AI that eases workforce burdens and are embedding these capabilities into their platforms.

Other big firms are making similar moves. Oracle (which now owns Cerner) is integrating AI into scheduling and billing. Nuance’s ambient clinical documentation AI (the Dragon Ambient eXperience) is already in many exam rooms, automatically writing doctor notes – arguably one of the earliest at-scale agentic AIs in healthcare, functioning as a silent clinical assistant. Even outside of software, service providers like large BPOs (business process outsourcing firms that handle medical billing, prior auth, etc.) are incorporating AI to stay competitive, since if they don’t, a startup might lure away their clients with a cheaper AI-driven offering.

For startups, this landscape means two things: validation and vigilance. The influx of capital validates that this space is real – it’s no longer speculative to talk about AI handling core operations, it’s happening. That helps convince customers that adopting AI agents is not risky fringe behavior but rather the direction the industry is headed. On the other hand, incumbent involvement means startups must move fast and build moats. If Epic and Microsoft offer a decent generalist AI that’s bundled into existing systems, why buy a point solution? The answer may lie in specialization and superior performance – startups can focus on niche workflows and fine-tune their AI to a level of efficacy that general platforms can’t match easily (at least not initially). Additionally, startups often have the advantage of being workflow-agnostic (able to sit on top of various systems) and more aggressively innovating on features and integrations. Many will choose partnership routes – for example, integrating with Epic’s open ecosystem or riding on Azure – to get distribution while maintaining a best-in-class product in their domain.

In essence, the competitive landscape is heating up. We have a gold rush of startups targeting every repetitive task in healthcare with AI, backed by serious capital. And we have the tech behemoths and health IT incumbents weaving AI into their offerings. This underscores that “AI workforce” solutions are not a fad; they are becoming table stakes. Founders need to be keenly aware of who else is attacking their problem and what unique edge they can maintain, whether it’s proprietary data, specialized models, or workflow depth. Fortunately, healthcare is so vast and complex that there are many corners where a nimble startup can build a stronghold before incumbents catch up. The key will be executing on a smart go-to-market and scaling strategy, which we turn to next.

Founder Playbook: GTM Strategy, ROI Framing, and Navigating Regulation

For founders building agentic AI solutions in healthcare, success will hinge not just on the technology, but on how you take it to market and operate within healthcare’s contours. Here are some strategic considerations:

1. Target the Right Buyer and Pain Point: As stressed earlier, framing is everything. Identify the budget owner who feels the pain of the problem you’re solving. If you have an AI that automates insurance verification, for instance, sell to the VP of Revenue Cycle or the COO, highlighting how it alleviates staffing shortages or cuts manual work – not just to the CIO as an IT efficiency tool. Many of the most successful deployments (like the startups we highlighted) started in a specific department with a champion who needed to solve a labor challenge. Whether it’s the call center director, the chief nursing officer, or the clinic manager, find that operational champion rather than relying solely on the IT steering committee. Aim to be categorized as “workforce augmentation” in the budget – this often gives you more runway to prove value than a tight IT line item.

2. Lead with ROI, Backed by Data: Healthcare executives are increasingly data-driven, and nothing opens doors faster than a clear ROI story. Since agentic AI solutions lend themselves to productivity metrics, build a compelling case early. For example: “Our pilot site saw a 30% reduction in nurse overtime hours within 3 months” or “Using our AI, billing staff were able to increase claims processed per day from 50 to 150, yielding an annualized $XM in cost savings.” Having such numbers (even if from a small sample) helps overcome the skepticism that often greets new tech. Wherever possible, tie your value to revenue or hard dollars – cost savings, additional patients seen, reduced outsourced spend, improved payer reimbursements, etc. Soft metrics (like patient satisfaction or clinician happiness) are nice but usually not sufficient alone to secure budget. One pragmatic move is to structure contracts with a pilot phase and clear success criteria; if you hit the targets (e.g., cutting average call handling time by 20%), the rollout and budget expansion become no-brainers. Essentially, let the results sell for you after that initial foot in the door.

3. Avoid the Regulatory Quagmire (When Possible): The FDA’s regulation of Software as a Medical Device (SaMD) can be a multi-year process and introduce significant overhead. A savvy strategy many AI startups use is to stay just outside the boundary of regulated clinical decision-making. That means focusing on use cases like administrative workflow, patient communication, care coordination, etc., rather than diagnostics or treatment recommendations. Hippocratic AI’s emphasis on “non-diagnostic” tasks is a deliberate choice to avoid FDA clearance needs . Similarly, an AI that writes draft clinical notes for a doctor or triages appointment requests is generally not practicing medicine by itself and can be deployed without regulatory approval. Founders should deeply understand the definitions: if your tool provides information for clinicians to consider (decision support) versus making autonomous clinical decisions, the regulatory implications differ. In cases where some FDA oversight is inevitable (say you do want to analyze medical images for insights), factor that into your timeline and capital needs – but if there’s a path to deliver value in an unregulated way, that often is the wiser initial route. Also, keep an eye on evolving guidance; regulators are paying attention to AI, and staying on the right side of compliance (privacy, security, and any emerging AI-specific rules) is critical for long-term viability.

4. Build Moats Through Workflow Integration and Data: In the agentic AI arena, moats come from embedding deeply into customer workflows and learning from data. The more your solution becomes a part of the daily routine, the harder it is to rip out. For example, if your AI schedules appointments autonomously, and over time it integrates with all the quirks of a clinic’s scheduling rules and patient preferences, it becomes the de facto scheduler that staff rely on. Replacing it with a generic tool would cause disruption. Integration with EHRs, call systems, and other infrastructure can be a moat (albeit one that requires effort – but once done, you have an edge). Data feedback loops are another moat: every interaction your AI has (every call analyzed, every care plan generated) can make it smarter in domain-specific ways. Over time, you might accumulate the largest dataset of, say, home health intake forms and outcomes. That proprietary data can improve your models beyond what a newcomer or big generic model could do, yielding better results and accuracy – which customers will care about. Moreover, incorporating clinician or user feedback to refine the AI’s actions builds trust and efficacy. This is a “soft” moat, but in healthcare trust is huge; if your product is known to be safe and effective because it has been honed in the field, that reputation itself is an asset. Finally, consider network effects or scale advantages: if your AI agent connects to, say, a network of providers and payers (imagine an AI that coordinates across organizations), having many participants makes it more valuable – an incumbent can’t easily replicate that network overnight.

5. Mind the Change Management: One pragmatic note – even the best AI workforce solution will fail if end-users don’t adopt it. Replacing or augmenting humans can provoke resistance (fear of job loss, distrust of AI decisions, etc.). Founders need a plan for change management: make the AI a tool that makes the human worker’s life better, not a threat. In practice, this can mean starting in “assistant” mode (co-pilot that the human can review or override) so that staff feel in control. It means providing training and smooth UX so using the AI isn’t more hassle than the old way. And it means identifying internal champions at the client who will advocate for the AI and help get buy-in from peers. This is the less glamorous, but absolutely vital, part of GTM in healthcare – navigating human factors and organizational culture. Often, positioning the AI as taking away the “boring, tedious tasks” and freeing humans for higher-value work is a message that can win people over. Also, if your economic buyer (like a COO) is pushing for it due to ROI, make sure to also win the hearts of the actual users (nurses, agents, etc.) by demonstrating how it reduces their burnout or workload. In the long run, agentic AI won’t replace all healthcare jobs, but it will change jobs – those who use it will find their roles evolving. Founders should be transparent about this and work to ensure that their product is viewed as a benefit, not a threat, by those on the front lines.

Long-Term Implications: Who Wins and the Impact on Healthcare Costs

As agentic AI becomes more pervasive, it’s worth contemplating the bigger picture: Who ultimately captures the value created by AI as a workforce, and how might this shift affect the cost of care system-wide?

In the near to mid-term, we can expect a distribution of value among multiple stakeholders:

• Startups and their Investors: In providing these AI workforce solutions, successful startups will generate significant enterprise value (as we’re already seeing with unicorn valuations). High margins and subscription-like revenue from these solutions can make for very profitable businesses. Investors are betting that these companies can capture a slice of the huge labor costs they are saving – essentially monetizing a portion of the efficiency gain. For example, if an AI saves a hospital $1M a year in labor, the startup might capture $300k of that as revenue, leaving $700k savings to the customer. At scale, that translates to robust profits. Over time, competition may drive pricing down, but the best-positioned AI companies could become essential platforms that command durable fees (much like EHRs became must-haves with hefty costs).
  
  
• Providers (Hospitals/Clinics): Healthcare providers stand to benefit through improved margins if they can reduce labor expenses or at least curb their growth. In a tight financial environment (many hospitals are operating at slim margins or losses post-2020), the ability to structurally remove cost is extremely attractive. We could see hospitals able to reinvest savings into other areas like quality improvement or new services. In theory, providers could also pass savings along in the form of lower prices for services, but historically healthcare doesn’t often lower prices – instead, the savings might slow down the annual cost increases or help the hospital stay solvent. Providers also benefit via workforce stability: AI taking on undesirable tasks might reduce burnout and turnover among staff, which has indirect financial benefits (retention of nurses, etc., avoiding expensive temp staffing).
  
  
• Payers (Insurers and Employers): Payers are a key indirect beneficiary. Many agentic AI solutions help ensure patients get appropriate, timely care (thus preventing costly complications) and streamline administrative dealings (claims, authorizations, customer service). If these lead to fewer unnecessary ER visits, better medication adherence, or quicker discharge processes, payers will save medical claim costs. Some payers are directly investing or partnering in this space (not just MA plans with DUOS, but even insurers backing startups like Hippocratic AI). Over time, payers might bake in expectations of AI efficiencies into their reimbursement models – for instance, if prior auth becomes cheap and instant, an insurer might require it more universally, knowing it’s not a burden with AI. Payers also win from member satisfaction if tools like AI concierges make the healthcare experience smoother. An interesting dynamic will be contracting: as providers save money with AI, payers might push for lower reimbursement increases, essentially attempting to claim some of the savings. This is analogous to how insurers push back on hospitals if, say, length of stay goes down due to better care coordination – they might argue costs should come down. So there may be a tug-of-war in capturing the value, but overall system efficiency does benefit payers.
  
  
• Patients: The end consumers of healthcare – patients – could be big winners if this AI-driven efficiency translates into more accessible, affordable care. In the long run, bending the cost curve down is crucial for patients (lower premiums, lower out-of-pocket costs) and for society at large. Agentic AI has the potential to structurally deflate the cost of care by removing some of the labor cost inflation that has plagued healthcare for decades. If a task that used to require a $30/hour employee for 1 hour can be done by AI in 5 minutes of compute time, that’s a huge productivity gain. Historically, productivity gains in other industries (like manufacturing) have led to lower consumer prices or at least enabled higher volume at the same cost. Healthcare hasn’t seen such productivity leaps in a long time – it’s one reason costs keep climbing. AI workforce solutions might finally change that. Patients will also see more convenience and access: digital agents can provide 24/7 service, short wait times, and more personalized interactions at scale. A patient might get immediate answers from an AI agent at midnight, whereas previously they’d wait hours or days for a human callback. In clinical settings, AI can extend care reach (e.g., more frequent check-ins for chronic patients via automated texts or calls, which keeps them healthier). So the value to patients is better service and potentially slower growth in bills.
  

In the long-term, if agentic AI becomes ubiquitous, we might witness a re-balancing of the workforce. The role of humans in healthcare could shift to higher-touch, higher-complexity activities (the “top of license” practice for clinicians, or more empathetic patient interactions that AI can’t replicate), while AI handles routine administrative and even some clinical tasks under supervision. The healthcare industry could gradually move away from its labor-intensive model, which could help tame the beast of healthcare inflation. Some estimate broader AI adoption could save 5–10% of total healthcare spending annually (on the order of $200–360 billion in the U.S. ) if applied effectively – savings that ultimately free up resources to either lower costs or reallocate to other needs.

Who loses in this scenario? Potentially, labor-intensive service providers or outsourcing businesses may find their models disrupted. Staffing agencies, BPO firms, or any middleman relying on inefficiency could be squeezed. Some roles in healthcare will evolve or even phase out over time – for example, medical scribes might not be needed if AI fully handles documentation, or call center headcount could be trimmed as AI agents handle more calls. This can create short-term friction in the labor market, although given the chronic shortages, it may be more of a re-deployment of people to where they’re truly needed (e.g., more nurses at bedside, fewer doing paperwork). Policymakers and institutions will need to manage this transition to ensure we upskill and transition workers accordingly.

Overall, the shift of AI from tool to workforce has the potential to drive a rare productivity revolution in healthcare – something that could bend the cost curve and improve care delivery if guided correctly. The winners will be those who proactively embrace and shape this trend (startups building the solutions, providers and payers deploying them intelligently, and patients who get more responsive care). Those who resist may find themselves on the wrong side of a more efficient paradigm.

Conclusion

What we are witnessing is the beginning of a new era in healthcare, one where the definition of “workforce” expands to include digital employees working alongside humans. Agentic AI is proving its worth not in futuristic visions, but in day-to-day operations – scheduling appointments, answering calls, filling forms, coordinating care, and more. By smartly framing these solutions as workforce enhancers (not just IT), founders are accelerating adoption and scaling into budgets that were previously untouchable for tech. The most successful ventures will be those that remain analytical in approach (proving ROI every step of the way), pragmatic about integration and change management, and strategic in navigating the complex healthcare ecosystem of stakeholders and regulations.

For healthcare founders and innovators, the charge is clear: focus on real problems, measure real results, and integrate AI in ways that make healthcare work better for everyone involved. The opportunity is not just to build another software tool, but to fundamentally reshape how work gets done in healthcare – making it more efficient, more human-centered (ironically by offloading the drudgery to machines), and ultimately more sustainable. As this shift gains momentum, it could help us finally break out of the cycle of rising costs and workforce burnout that has long plagued the industry. In a sector often criticized for its resistance to change, the rise of AI as a digital workforce may well be the disruptive force that, managed wisely, leads to a structurally better healthcare system. And that is a future worth striving for.

Sources:

• American Hospital Association – Hospital labor as ~60% of costs .
  
  
• Definitive Healthcare – IT expenses ~2.3% of hospital operating spend .
  
  
• Fierce Healthcare – TrampolineAI upskills call center agents with AI, real-time support & notes .
  
  
• Empowered Patient Podcast – Vivid Health automating home health paperwork and using AI voice agents .
  
  
• HIT Consultant – Cascala Health’s AI for care transitions to prevent patients getting lost in handoffs .
  
  
• Translucent Health – “AI labor” for FP&A, automating analysis for providers .
  
  
• DUOS – AI-driven matching of seniors to benefits/resources (86% faster navigation) .
  
  
• TechCrunch – Hippocratic AI $141M Series B for non-diagnostic patient-facing agents .
  
  
• Bessemer/Rocket Digital Health – Margin comparison: SaaS ~70% vs tech-enabled services ~45% gross margin .
  
  
• MedCity News – Definition of agentic AI in healthcare (AI agents as autonomous, task-specific systems) .
  
  
• Epic/Microsoft release – Integration of GPT-4 into Epic EHR for efficiency (drafting responses, etc.) .
  
  
• Healthcare Dive – Potential 5–10% ($200–360B) annual healthcare cost savings from AI at scale .
  
  

‍